Targeting Abeta phagocytosis by blocking IRAK-M innate immunity in Alzheimer mice
通过阻断阿尔茨海默病小鼠的 IRAK-M 先天免疫来靶向 Abeta 吞噬作用
基本信息
- 批准号:8760213
- 负责人:
- 金额:$ 3.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-19 至 2015-09-18
- 项目状态:已结题
- 来源:
- 关键词:AblationAffectAgeAllelesAlzheimer like pathologyAlzheimer&aposs DiseaseAmericanAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAmyloid depositionAmyloidosisAnimal BehaviorAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAttenuatedBehavioral AssayBiochemicalBiological AssayBiological ModelsBrainBrain PathologyCellsCentrifugationCerebrumChronicComplexConflict (Psychology)Confocal MicroscopyDataDementiaDepositionDiseaseDisinhibitionDissociationDoseEducationEducational workshopEnzyme-Linked Immunosorbent AssayEventFamilyFluoresceinGenesGeneticGoalsGrantHomeostasisHumanHuman GeneticsImageImmuneImmune Cell ActivationImmune responseImmune systemImmunohistochemistryImmunologyImpaired cognitionIn VitroInflammatoryInflammatory ResponseInterleukin-1LabelLaboratoriesLysosomesMeasurementMeasuresMediatingMethodsMicrogliaMolecularMusMutationNatural ImmunityNeuraxisNeurodegenerative DisordersPathogenesisPathologyPb clearancePhagocytesPhagocytosisPhosphotransferasesPhysiologic pulsePlayPresenile Alzheimer DementiaProcessProductionPublic HealthReactionReceptor SignalingReportingRoleSenile PlaquesSerineSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNATNF receptor-associated factor 6TestingThreonineTimeLineToll-like receptor 6Toll-like receptorsTrainingTransgenic MiceWestern BlottingWild Type MouseWorkWritingamyloid pathologycareer developmentchemokinecognitive functioncytokinedesigndoctoral studentimprovedin vivoinsightmacrophagemonocytemorris water mazemouse modelmutantneurofibrillary tangle formationneuroinflammationneuropathologynovelobject recognitionoffspringpathogenpeptide Apresenilin-1presenilin-2preventpublic health relevancereceptorresearch studyresponsescreeningsensorsextau Proteins
项目摘要
Project Summary/Abstract
Alzheimer's disease (AD) is the most common dementia, and is hallmarked by deposition of A¿ peptides as
'senile' ¿-amyloid plaques, neuropathology, and neuroinflammation. Toll-like receptors (TLRs) are germline-
encoded sensors of pathogens by cells of the innate immune system and play differential roles in amyloid
homeostasis. TLRs transduce their signals through the serine/threonine IL-1 receptor-associated kinase
(IRAK). The IRAK family is chiefly comprised of kinases that positively regulate TLR signaling, with the notable
exception of the inhibitory kinase, IRAK-M. IRAK-M expression is specific to cells of monocytic lineage,
including microglia, and plays a critical role in keeping innate immune responses in check. To test whether
IRAK-M participated in cerebral amyloid remodeling, we crossed mice deficient in IRAK-M (IRAK-M-/-) with
mice over expressing mutant human amyloid precursor protein, the APPPS1 mouse model of cerebral
amyloidosis. We then evaluated the state of immune cell activation and cerebral A¿ burden in age and sex-
matched littermates from three groups: APPPS1-IRAK-M+/+, APPPS1-IRAK-M-/+, and APPPS1-IRAK-M-/- mice.
Preliminary data showed a gene dose-dependent effect where microglial activation inversely correlated with
IRAK-M allele number. Further, brain parenchymal A¿ abundance was correspondingly attenuated in APPPS1-
IRAK-M-/- mice as measured by biochemical approaches. Interestingly, confocal imaging of APPPS1-
IRAK-M-/- mouse brains revealed A¿ colocalization with the lysosomal marker LAMP1, suggesting a
phagocytic mechanism of IRAK-M-/- microglia-mediated A¿ clearance. This proposal is designed to test
whether disinhibition of IRAK-M affects microglial remodeling of amyloid pathology. The focus of Specific Aim
1 will be to further characterize brain pathology and animal behavior in IRAK-M deficient Alzheimer mice. The
proposed experiments will elucidate the impact of IRAK-M deficiency on the microglial response to Alzheimer-
like pathology, including its influence on cognitive impairment. We will then evaluate cytokine/chemokine
responses in vivo to determine the whether IRAK-M deficiency promotes pro- or anti-inflammatory reactions of
microglia in APPPS1-IRAK-M-/- mice. Specific Aim 2 will further assess phagocytosis of A¿ in APPPS1-IRAK-
M-/- microglia and determine the function of IRAK-M in A¿ phagocytosis. The applicant is a third-year doctoral
student in the laboratory of Dr. Terrence Town, who has been working in the field of AD innate immunology for
the past 17 years. The proposed training plan outlines a set of career development activities and scientific
workshops - e.g. advanced education in neuropathology, animal behavior and grant writing - to facilitate
completion of this work.
项目摘要/摘要
阿尔茨海默氏病(AD)是最常见的痴呆症,并以A肽的沉积为标志
“老年” - 淀粉样斑块,神经病理学和神经炎症。 Toll样受体(TLR)是种系
通过先天免疫系统细胞编码的病原体传感器,并在淀粉样蛋白中起鉴别作用
稳态。 TLR通过丝氨酸/苏氨酸IL-1受体相关激酶转导信号
(irak)。 Irak家族主要积累了激酶,它们以著名的
抑制性激酶除外。 IRAK-M表达特定于单核细胞谱系的细胞,
包括小胶质细胞在内,并且在控制先天免疫反应中起着至关重要的作用。测试是否
Irak-M参加了脑淀粉样蛋白的重塑,我们将缺乏IRAK-M(IRAK-M - / - )的小鼠与
小鼠超过表达突变的人淀粉样蛋白前体蛋白,脑的AppPS1小鼠模型
淀粉样变性。然后,我们评估了免疫细胞激活状态和年龄和性别负担
匹配三个组的同窝室:appps1-irak-m+/+,appps1-irak-m - /+和appps1-irak-m - / - 小鼠。
初步数据显示了基因剂量依赖性效应,其中小胶质细胞激活与
irak-m等位基因编号。此外,在AppPS1-
通过生化方法测量的IRAK-M - / - 小鼠。有趣的是,AppPS1-的共聚焦成像 -
irak-M - / - 小鼠大脑显示与溶酶体标记LAMP1共定位,这表明
irak-M - / - 小胶质细胞介导的清除率的吞噬机制。该建议旨在测试
IRAK-M的抑制是否会影响淀粉样病理学的小胶质重塑。特定目标的重点
1将进一步表征IRAK-M缺乏阿尔茨海默氏症小鼠中的脑病理学和动物行为。这
提出的实验将阐明Irak-M缺乏对小胶质细胞对阿尔茨海默氏症的影响的影响
就像病理一样,包括对认知障碍的影响。然后,我们将评估细胞因子/趋化因子
体内反应以确定IRAK-M缺乏症是否促进了促或抗炎反应
Appps1-irak-M - / - 小鼠中的小胶质细胞。具体目标2将进一步评估Appps1-irak-中A的吞噬作用
M - / - 小胶质细胞,并确定IRAK-M在吞噬作用中的功能。申请人是三年级的博士
Terrence Town博士实验室的学生,他一直在AD先天免疫学领域工作
过去17年。拟议的培训计划概述了一系列职业发展活动和科学
讲习班 - 例如神经病理学,动物行为和赠款写作的高级教育 - 促进
完成这项工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Gate其他文献
David Gate的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Gate', 18)}}的其他基金
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10674878 - 财政年份:2022
- 资助金额:
$ 3.63万 - 项目类别:
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10515592 - 财政年份:2022
- 资助金额:
$ 3.63万 - 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
- 批准号:
10054559 - 财政年份:2020
- 资助金额:
$ 3.63万 - 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
- 批准号:
10529475 - 财政年份:2020
- 资助金额:
$ 3.63万 - 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
- 批准号:
10207808 - 财政年份:2020
- 资助金额:
$ 3.63万 - 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
- 批准号:
10545096 - 财政年份:2020
- 资助金额:
$ 3.63万 - 项目类别:
Reversing epigenetic changes in aged microglia via young circulatory factors
通过年轻循环因子逆转衰老小胶质细胞的表观遗传变化
- 批准号:
9812746 - 财政年份:2018
- 资助金额:
$ 3.63万 - 项目类别:
Targeting Abeta phagocytosis by blocking IRAK-M innate immunity in Alzheimer mice
通过阻断阿尔茨海默病小鼠的 IRAK-M 先天免疫来靶向 Abeta 吞噬作用
- 批准号:
8649898 - 财政年份:2013
- 资助金额:
$ 3.63万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Bone Sialoprotein in Modulating Periodontal Development and Repair
骨唾液酸蛋白在调节牙周发育和修复中的作用
- 批准号:
10752141 - 财政年份:2023
- 资助金额:
$ 3.63万 - 项目类别:
Hypothalamic Sleep-Wake Neuron Defects in Alzheimer’s disease
阿尔茨海默病中的下丘脑睡眠-觉醒神经元缺陷
- 批准号:
10770001 - 财政年份:2023
- 资助金额:
$ 3.63万 - 项目类别:
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
优化小分子力学模拟治疗与年龄相关的骨质疏松症。
- 批准号:
10807685 - 财政年份:2023
- 资助金额:
$ 3.63万 - 项目类别:
Upregulation of progranulin in a human iPSC-derived neurovascular model of GRN-associated Frontotemporal Dementia
GRN 相关额颞叶痴呆的人 iPSC 衍生神经血管模型中颗粒体蛋白前体的上调
- 批准号:
10789724 - 财政年份:2023
- 资助金额:
$ 3.63万 - 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
- 批准号:
10717111 - 财政年份:2023
- 资助金额:
$ 3.63万 - 项目类别: